Comments
Torrent Pharmaceuticals posted a net profit of Rs 188 crore for the quarter ended June 2017 as against Rs 292 crore in the corresponding quarter last year, showing a decline of 35 per cent on a year-on-year basis.
The company's revenues for the quarter fell to Rs 1,374 crore as against RS 1,551 crore during the quarter under review.
"Previous period includes exceptional revenues and profits, which was primarily on account of the launch of a new product in the US market, which had limited competition," a company statement said.
EBIDTA for the quarter stood at Rs 400 crore as against Rs 462 crore during the same period last year.
Torrent Pharma shares gained over 5.5 per cent on the National Stock Exchange (NSE) on Monday to close at Rs 1,315.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.